DNA
Ginkgo Bioworks Holdings, Inc. NYSE Listed Apr 19, 2021$10.35
Pre-mkt
$9.46
-8.64%
Mkt Cap $674.2M
52w Low $5.37
40.8% of range
52w High $17.58
50d MA $7.37
200d MA $10.04
P/E (TTM)
-1.7x
EV/EBITDA
-2.8x
P/B
1.1x
Debt/Equity
0.8x
ROE
-61.5%
P/FCF
-2.6x
RSI (14)
—
ATR (14)
—
Beta
1.57
50d MA
$7.37
200d MA
$10.04
Avg Volume
1.2M
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
27 Drydock Avenue · Boston, MA 02210 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | -1.80 | -1.42 | +21.1% | 9.71 | -17.5% | -30.5% | -27.4% | -31.0% | -31.1% | -29.6% | — |
| Nov 6, 2025 | AMC | -1.24 | -1.45 | -16.9% | 11.30 | -8.9% | -20.8% | -22.4% | -25.1% | -26.0% | -29.2% | — |
| Aug 7, 2025 | AMC | -1.44 | -1.10 | +23.6% | 13.46 | +4.4% | -8.7% | -11.7% | -14.1% | -1.5% | -4.2% | — |
| May 6, 2025 | AMC | -1.23 | -1.58 | -28.5% | 6.45 | +5.9% | +14.7% | +22.0% | +20.3% | +28.8% | +25.9% | — |
| Feb 25, 2025 | AMC | -1.45 | -1.82 | -25.5% | 10.29 | -14.3% | -11.5% | -16.0% | -19.9% | -22.2% | -21.1% | — |
| Nov 12, 2024 | AMC | -2.40 | -1.08 | +55.0% | 8.39 | +8.3% | +2.5% | -12.9% | -24.1% | -24.6% | -23.1% | — |
| Aug 8, 2024 | AMC | -3.20 | -3.20 | +0.0% | 11.43 | +8.5% | -5.4% | -8.3% | -1.7% | -15.3% | -10.9% | — |
| May 9, 2024 | AMC | -3.20 | -3.20 | +0.0% | 36.80 | -13.4% | -17.3% | -8.6% | -6.2% | -8.8% | -8.8% | — |
| Feb 29, 2024 | AMC | -3.60 | -3.60 | +0.0% | 60.80 | -15.8% | -15.1% | -17.1% | -24.3% | -19.7% | -21.1% | — |
| Nov 8, 2023 | AMC | -3.60 | -3.60 | +0.0% | 59.60 | -6.7% | -15.4% | -14.1% | -14.1% | -3.4% | +4.7% | — |
| Aug 9, 2023 | AMC | -3.60 | -3.60 | +0.0% | 80.40 | -4.5% | -12.9% | -7.0% | -10.9% | -11.9% | -18.9% | — |
| May 10, 2023 | AMC | -3.60 | -3.20 | +11.1% | 54.00 | -7.4% | -1.5% | -8.9% | -2.2% | -7.4% | -5.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 | BTIG | Maintains | Sell → Sell | — | $6.83 | $6.58 | -3.7% | -6.3% | -0.4% | -1.2% | +0.0% | -5.0% |
| Jan 8 | TD Cowen | Maintains | Buy → Buy | — | $9.61 | $9.33 | -2.9% | -5.7% | -3.9% | -0.5% | +0.1% | +2.5% |
| Aug 25 | BTIG | Maintains | Sell → Sell | — | $12.55 | $12.37 | -1.4% | -4.0% | +1.8% | -1.6% | -3.0% | +1.0% |
| Sep 20 | TD Cowen | Maintains | Buy → Buy | — | $8.31 | $8.31 | +0.0% | -3.6% | -5.8% | -2.9% | -6.6% | -7.3% |
| Aug 23 | BTIG | Maintains | Sell → Sell | — | $8.30 | $8.40 | +1.2% | -1.8% | -5.1% | -9.3% | -14.7% | -14.6% |
| Jul 9 | Goldman Sachs | Maintains | Sell → Sell | — | $13.62 | $13.60 | -0.1% | -9.4% | -4.6% | -5.9% | -15.4% | -14.8% |
| Jun 26 | BTIG | Maintains | Sell → Sell | — | $12.80 | $12.00 | -6.2% | -11.2% | -3.4% | +4.5% | +1.0% | +8.3% |
| May 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $34.51 | $35.92 | +4.1% | -2.8% | -2.8% | -6.6% | -11.2% | -15.2% |
| May 15 | BTIG | Downgrade | Neutral → Sell | — | $34.51 | $35.92 | +4.1% | -2.8% | -2.8% | -6.6% | -11.2% | -15.2% |
| May 10 | William Blair | Downgrade | Market Perform → Underperform | — | $36.80 | $31.88 | -13.4% | -17.3% | -8.6% | -6.2% | -8.8% | -8.8% |
| Mar 1 | TD Cowen | Maintains | Outperform → Outperform | — | $60.80 | $51.20 | -15.8% | -15.1% | -17.1% | -24.3% | -19.7% | -21.1% |
| Jan 23 | Goldman Sachs | Maintains | Sell → Sell | — | $49.20 | $50.40 | +2.4% | +3.3% | +0.8% | +2.4% | +4.9% | +9.8% |
| Jan 22 | Goldman Sachs | Maintains | Sell → Sell | — | $48.40 | $48.80 | +0.8% | +1.7% | +5.0% | +2.5% | +4.1% | +6.6% |
| Nov 15 | Raymond James | Downgrade | Outperform → Market Perform | — | $57.60 | $58.00 | +0.7% | +8.3% | +1.4% | +5.6% | +6.2% | -0.7% |
| Nov 14 | Raymond James | Downgrade | Outperform → Market Perform | — | $51.20 | $54.00 | +5.5% | +12.5% | +21.9% | +14.1% | +18.8% | +19.5% |
| Nov 9 | BTIG | Downgrade | Buy → Neutral | — | $59.60 | $55.60 | -6.7% | -15.4% | -14.1% | -14.1% | -3.4% | +4.7% |
| Jun 5 | Goldman Sachs | Maintains | Sell → Sell | — | $64.80 | $64.40 | -0.6% | +1.9% | +13.0% | +9.9% | +8.6% | +14.2% |
| Jun 2 | Goldman Sachs | Downgrade | Neutral → Sell | — | $67.20 | $65.20 | -3.0% | -3.6% | -1.8% | +8.9% | +6.0% | +4.8% |
| May 11 | William Blair | Downgrade | Outperform → Market Perform | — | $54.00 | $50.00 | -7.4% | -1.5% | -8.9% | -2.2% | -7.4% | -5.9% |
| Nov 29 | Berenberg | Maintains | Buy → Buy | — | $73.60 | $75.20 | +2.2% | +0.5% | +8.2% | +7.6% | +8.2% | -2.2% |
| Oct 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $125.60 | $131.60 | +4.8% | +12.1% | +5.4% | +2.9% | -1.6% | -8.0% |
| Aug 16 | BTIG | Maintains | Buy → Buy | — | $139.60 | $166.80 | +19.5% | +7.2% | -6.6% | -6.9% | -18.3% | -22.9% |
| Aug 16 | Raymond James | Maintains | Outperform → Outperform | — | $139.60 | $166.80 | +19.5% | +7.2% | -6.6% | -6.9% | -18.3% | -22.9% |
| Jun 16 | Jefferies | Maintains | Buy → Buy | — | $103.60 | $97.60 | -5.8% | -10.4% | -8.5% | -5.8% | -3.9% | +13.5% |
| May 18 | BofA Securities | Downgrade | Neutral → Underperform | — | $109.60 | $103.60 | -5.5% | -11.3% | -8.0% | -4.7% | -2.2% | -5.8% |
| Mar 2 | Cowen & Co. | Maintains | Outperform → Outperform | — | $171.60 | $177.20 | +3.3% | -0.9% | -10.0% | -20.0% | -19.6% | -18.9% |
| Feb 23 | Goldman Sachs | Maintains | Neutral → Neutral | — | $168.80 | $176.40 | +4.5% | +1.2% | +9.2% | +4.5% | +6.6% | +1.7% |
| Feb 1 | BofA Securities | Maintains | Neutral → Neutral | — | $239.20 | $241.60 | +1.0% | +4.0% | +2.7% | -4.0% | +1.0% | +2.0% |
| Jan 28 | BofA Securities | Maintains | Buy → Buy | — | $186.00 | $190.40 | +2.4% | +6.9% | +28.6% | +33.8% | +32.0% | +23.4% |
| Jan 7 | BTIG | Maintains | Buy → Buy | — | $276.00 | $281.20 | +1.9% | -1.2% | -2.8% | -1.0% | -9.3% | -11.0% |
| Oct 13 | Raymond James | Maintains | Outperform → Outperform | — | $433.20 | $444.80 | +2.7% | -5.4% | +7.4% | +10.0% | +13.8% | +36.7% |
| Oct 12 | William Blair | Maintains | Outperform → Outperform | — | $378.80 | $387.20 | +2.2% | +14.4% | +8.2% | +22.8% | +25.8% | +30.1% |
| Sep 20 | HSBC | Maintains | Buy → Buy | — | $487.20 | $482.00 | -1.1% | -8.8% | -3.9% | -2.5% | +1.0% | +3.4% |
No insider trades available.
8-K · 2.02
!! High
Ginkgo Bioworks Holdings, Inc. -- 8-K 2.02: Earnings Results
Ginkgo Bioworks reported Q1 2026 financial results, providing investors with an update on the synthetic biology company's operational performance and financial condition.
May 7
8-K · 2.01
!!! Very High
Unknown — 8-K 2.01: Acquisition Completed
Ginkgo Bioworks completed a major acquisition, reshaping its balance sheet and operational scale as of year-end 2025; investors should monitor integration execution and synergy realization for stock impact.
Apr 7
8-K · 5.02
!!! Very High
Tivic Health Systems, Inc. -- 8-K 5.02: Executive Change
Tivic Health Systems appointed Michael K. Handley as Chief Executive Officer, signaling leadership transition that investors should monitor for strategic direction changes and operational impact.
Mar 4
8-K · 1.01
!! High
Ginkgo Bioworks Holdings, Inc. -- 8-K 1.01: Material Agreement
Ginkgo Bioworks acquired Tower Biosecurity through a stock purchase agreement, expanding its biosecurity and detection capabilities in synthetic biology applications.
Feb 27
8-K
Ginkgo Bioworks Holdings, Inc. -- 8-K Filing
Ginkgo Bioworks experienced a 24% year-over-year revenue decline in Q4 2025, falling to $33 million from $44 million, signaling potential challenges in executing its synthetic biology commercialization strategy.
Feb 26
Data updated apr 25, 2026 5:29am
· Source: massive.com